PHARMIMPULSE: what changed
Position among the sector peers
Sector benchmark: create a free account or sign in to use this tool.
You see every sector peer as a dot per ratio, with the company in two financial years and every ratio over five years against the sector.
What moved between 2024 and 2025
Largest movements
- Receivables within one year -€271,320
down €271,320 (-75.4%), from €360,040 to €88,720
of which Trade receivables: -€253,652
- Cash -€11,875
down €11,875 (-78.9%), from €15,050 to €3,175
mainly Trade debts (-€139,062) and Net result for the year (-€81,057)
- Intangible fixed assets +€9,398
new in 2025: €9,398
- Trade debts -€139,062
down €139,062 (-90.4%), from €153,837 to €14,775
- Profit (loss) carried forward -€81,057
new in 2025: -€81,057
- Tax, wage and social debts -€44,377
down €44,377 (-37.9%), from €117,153 to €72,776
of which Remuneration and social security: -€36,799
- Short-term financial debts -€8,714
down €8,714 (-38.2%), from €22,819 to €14,104
- Gross operating margin -€671,356
down €671,356 (-79.7%), from €842,528 to €171,172
- Staff costs -€597,067
down €597,067 (-71.3%), from €837,838 to €240,771
Change in the result, 2024 to 2025
The net result is not in both sets of accounts. Without it the difference cannot be explained line by line.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €384,361 | €109,700 | -€274,661 | -71.5% |
| Fixed assets | 21/28 | €8,453 | €16,985 | +€8,532 | +101% |
| Intangible fixed assets | 21 | - | €9,398 | +€9,398 | |
| Tangible fixed assets | 22/27 | €8,453 | €7,587 | -€866 | -10.2% |
| Furniture and vehicles | 24 | - | €408 | +€408 | |
| Other tangible fixed assets | 26 | €8,453 | €7,178 | -€1,275 | -15.1% |
| Current assets | 29/58 | €375,908 | €92,715 | -€283,193 | -75.3% |
| Amounts receivable within one year | 40/41 | €360,040 | €88,720 | -€271,320 | -75.4% |
| Trade receivables | 40 | €306,286 | €52,634 | -€253,652 | -82.8% |
| Other amounts receivable | 41 | €53,754 | €36,086 | -€17,668 | -32.9% |
| Cash at bank and in hand | 54/58 | €15,050 | €3,175 | -€11,875 | -78.9% |
| Deferred charges and accrued income | 490/1 | €818 | €820 | +€1 | +0.2% |
| Total equity and liabilities | 10/49 | €384,361 | €109,700 | -€274,661 | -71.5% |
| Equity | 10/15 | €3,750 | -€77,307 | -€81,057 | |
| Contributions | 10/11 | €3,750 | €3,750 | = | 0.0% |
| Contributions outside capital | 11 | €3,750 | €3,750 | = | 0.0% |
| Other | 1109/19 | €3,750 | €3,750 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | -€81,057 | -€81,057 | |
| Amounts payable | 17/49 | €380,611 | €187,007 | -€193,604 | -50.9% |
| Amounts payable within one year | 42/48 | €380,611 | €187,007 | -€193,604 | -50.9% |
| Financial debts | 43 | €22,819 | €14,104 | -€8,714 | -38.2% |
| Credit institutions | 430/8 | €22,819 | €14,104 | -€8,714 | -38.2% |
| Trade debts | 44 | €153,837 | €14,775 | -€139,062 | -90.4% |
| Suppliers | 440/4 | €153,837 | €14,775 | -€139,062 | -90.4% |
| Taxes, remuneration and social security | 45 | €117,153 | €72,776 | -€44,377 | -37.9% |
| Taxes | 450/3 | €38,292 | €30,714 | -€7,578 | -19.8% |
| Remuneration and social security | 454/9 | €78,861 | €42,062 | -€36,799 | -46.7% |
| Other amounts payable | 47/48 | €86,803 | €85,352 | -€1,450 | -1.7% |
| Remuneration, social security and pensions | 62 | €837,838 | €240,771 | -€597,067 | -71.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,275 | €1,464 | +€190 | +14.9% |
| Other operating charges | 640/8 | - | €400 | +€400 | |
| Gross operating margin | 9900 | €842,528 | €171,172 | -€671,356 | -79.7% |
| Operating profit (loss) | 9901 | €3,416 | -€71,463 | -€74,879 | |
| Financial income | 75/76B | €468 | €1,136 | +€669 | +143% |
| Recurring financial income | 75 | €468 | €1,136 | +€669 | +143% |
| Financial charges | 65/66B | €3,884 | €2,807 | -€1,077 | -27.7% |
| Recurring financial charges | 65 | €3,884 | €2,807 | -€1,077 | -27.7% |
| Profit (loss) for the period before taxes | 9903 | - | -€73,133 | -€73,133 | |
| Income taxes | 67/77 | - | €7,924 | +€7,924 | |
| Profit (loss) for the period | 9904 | - | -€81,057 | -€81,057 | |
| Profit (loss) for the period to be appropriated | 9905 | - | -€81,057 | -€81,057 |
Value
latest balance sheet 31-12-2025 · indication, not a valuation or adviceIndicative value of the equity
Indication, not a valuation or adviceMidpoint €0 · adjusted equity only
Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50% revaluation €0 other adjustment €0 EBITDA multiple
The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.
Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.
Adjusted equity
- Equity (10/15)
- -€77,307
- Formation expenses (20)
- €0
- Intangible fixed assets (21)
- -€9,398
- Revaluation of assets
- €0
- Deferred tax on the revaluation
- €0
- Other adjustment
- €0
- Adjusted equity
- -€86,706
Capitalised earnings
- 2025
- -€81,057
- 2024
- -
- 2022
- -
- 2021
- -
- excluding non-recurring income and charges
- -
- 2020
- -
- Average result, excluding non-recurring income and charges
- -€81,057
- Divided by the capitalisation rate
- 14% / 12% / 10%
- Capitalised earnings
- not meaningful, as the average result is zero or negative
Your EBITDA multiple
- EBITDA 2025
- -€69,999
- Net financial debt
- €10,929
- Your multiple
- -
- Value with your multiple
- -
These accounts do not break down the debts after one year. They count in full as financial debt.
Limits of the indication
- Checked holds no market prices or comparable transactions.
- Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
- Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
- The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.
For a valuation to base a decision on, go to a company auditor or a certified accountant.
Next steps
Calculation and sources
Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 8 November 2026 via checked.be.